Carolyn Quist
Obstetrics & Gynecology · Fort Worth, TXNPI 1649272972
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,656 of the $4,324 with a category attached, or 84.5%. It is spread thinly across 35 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,491 and has fallen 92.1% since, to $117 in 2025.
Across 161 payments — averaging $26.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$724
- AbbVie$703
- Daiichi Sankyo Inc.$388
- Astellas Pharma US Inc$280
- Minerva Surgical, Inc$222
- Amgen$206
- plus $2K from 29 others
Across 11 payments — averaging $791.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$9K
What the payments were for
- Travel & lodging$56613%
- Food & beverage$3,65685%
- Education$1032%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 6 | $724 |
| AbbVie(2 entities) | 35 | $703 |
| Daiichi Sankyo Inc. | 25 | $388 |
| Astellas Pharma US Inc | 8 | $280 |
| Minerva Surgical, Inc | 2 | $222 |
| Amgen | 5 | $206 |
| Therapeuticsmd, Inc. | 7 | $194 |
| Mayne Pharma Commercial LLC | 4 | $179 |
| Lilly USA, LLC | 9 | $157 |
| Millicent US Inc | 10 | $149 |
| Hologic Sales And Service, LLC | 3 | $143 |
| Radius Health, Inc. | 6 | $140 |
| Intuitive Surgical | 1 | $134 |
| Virtus Pharmaceuticals LLC | 7 | $112 |
| Exact Sciences | 5 | $81 |
| Pfizer | 3 | $54 |
| Mycovia Pharmaceuticals, Inc. | 2 | $53 |
| Shield Therapeutics Inc | 2 | $52 |
| Aspira Women's Health Inc | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| AMAG Pharmaceuticals, Inc. | 2 | $34 |
| Alvogen Inc | 1 | $25 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Mylan Pharmaceuticals Inc. | 1 | $20 |
| Vertical Pharmaceuticals, LLC | 1 | $20 |
| Agile Therapeutics, Inc. | 1 | $20 |
| Urovant Sciences Inc | 1 | $19 |
| Myovant Sciences Inc. | 1 | $18 |
| LSI Solutions Inc | 1 | $17 |
| Organon | 2 | $15 |
| Ascend Therapeutics US, LLC | 1 | $15 |
| Cumberland Pharmaceuticals, Inc. | 1 | $12 |
| Merck | 1 | $12 |
| Vistapharm, Inc. | 1 | $12 |
| Avion Pharmaceuticals | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$527
- UBRELVY$234
- Da Vinci Surgical System$134
- Myosure$125
- NovaSure$125
- Endometrial Ablation System (Device)$125
- NEXTSTELLIS$123
- EVENITY$122
- BIJUVA$120
- Veozah$116
How this compares
$4,324 in reported general payments places this provider in the 80th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 28 | $2,858 |
| ProgesteroneProgesterone, Micronized | 80 | $2,845 |
| EvamistEstradiol | 15 | $1,989 |
| Estradiol | 24 | $1,302 |
| Np ThyroidThyroid,pork | 13 | $1,076 |
| Finasteride | 12 | $176 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Fort Worth
- David MorelandFort Worth$63K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.